SOD1
SOD1 encodes a cytosolic antioxidant enzyme that converts superoxide radicals into hydrogen peroxide, supporting redox balance across tissues. Pathogenic SOD1 variants cause a subset of familial amyotrophic lateral sclerosis, often through toxic protein misfolding.
Key Takeaways
- •SOD1 encodes a key antioxidant enzyme that converts superoxide radicals into hydrogen peroxide.
- •Pathogenic SOD1 mutations cause a subset of familial ALS, often through toxic protein misfolding rather than simple loss of function.
- •Misfolded SOD1 can stress mitochondria, ER proteostasis, and neuroinflammatory circuits, accelerating motor neuron injury.
- •Genotype-specific therapies, including antisense approaches, are a major translational strategy for SOD1-associated ALS.
Basic Information
- Gene Symbol
- SOD1
- Full Name
- Superoxide Dismutase 1
- Also Known As
- Cu,Zn-SODALS1
- Location
- 21q22.11
- Protein Type
- Antioxidant enzyme
- Protein Family
- Superoxide dismutase family
Related Isoforms
Key SNPs
Common pathogenic SOD1 mutation associated with aggressive familial ALS in some populations.
Well-known SOD1 mutation with variable inheritance patterns and phenotypes across populations.
Classic mutation used in many transgenic models of ALS and linked to protein misfolding.
Pathogenic mutation associated with familial ALS and variable age of onset.
Mutation associated with motor neuron disease and altered SOD1 stability.
Metal-binding region mutation that can destabilize SOD1 folding and enzymatic function.
Example of a familial ALS-associated missense variant affecting SOD1 stability.
Overview
SOD1 (Superoxide Dismutase 1) is a widely expressed antioxidant enzyme that catalyzes conversion of superoxide radicals into hydrogen peroxide. This reaction is a core defense against oxidative damage, especially in high-metabolic tissues such as the nervous system.
In ALS, many pathogenic SOD1 variants cause toxic gain-of-function biology driven by protein misfolding, aggregation, and downstream cellular stress. Motor neurons are especially vulnerable to combined oxidative load, mitochondrial stress, and proteostasis failure, which can be amplified by misfolded SOD1 species.
Conceptual Model
A simplified mental model for the pathway:
In SOD1 ALS, toxic misfolded species can amplify stress in neurons and glia even when enzymatic activity is partly preserved.
Core Health Impacts
- • Superoxide detox: Detoxifies superoxide and limits oxidative damage.
- • Redox signaling: Supports redox balance that influences cellular stress signaling.
- • Mito resilience: Contributes to mitochondrial resilience under high metabolic load.
- • Proteostasis: Misfolded variants increase proteostasis burden and can activate glial toxicity.
- • ALS protection: Pathogenic mutations can drive familial ALS through toxic gain-of-function biology.
Protein Domains
Metal-binding core
Copper and zinc binding stabilize SOD1 folding and enable catalysis. Dysmetallation can promote misfolding.
Dimer interface
SOD1 forms stable dimers. Mutations that destabilize dimerization can increase aggregation propensity.
Loop regions
Disulfide state and flexible loops influence stability. Many ALS mutations increase population of destabilized conformations.
Upstream Regulators
CCS Activator
Copper chaperone; delivers copper to SOD1 and supports maturation of the properly folded enzyme.
Metal availability Activator
Zinc and copper binding stabilize SOD1 structure; dysmetallation can promote misfolding.
Oxidative stress Activator
High superoxide production increases reliance on SOD1 activity.
Mitochondrial import Modulator
SOD1 can localize to mitochondria; mitochondrial stress can amplify misfolding.
Proteostasis capacity Inhibitor
Chaperones, proteasome, and autophagy limit accumulation of misfolded SOD1 species.
Inflammation Activator
Neuroinflammation can increase oxidative burden and stress motor neurons.
Downstream Targets
Superoxide Inhibits
SOD1 converts superoxide radicals to hydrogen peroxide, limiting oxidative damage.
Redox balance Activates
By limiting superoxide, SOD1 influences downstream redox signaling.
Mitochondria Activates
SOD1 dysfunction or misfolding can impair mitochondria, increasing energetic failure.
ER stress Activates
Misfolded SOD1 can trigger unfolded protein responses and overload quality control.
Neuroinflammation Activates
Motor neuron injury and protein aggregates activate microglia and astrocytes.
Motor neuron survival Activates
Net effects include axonal degeneration and progressive weakness.
Role in Aging
Aging increases vulnerability to oxidative stress and proteostasis failure. Even when SOD1 itself is not mutated, age-related declines in mitochondrial function, chaperones, and lysosomal capacity can amplify downstream injury.
Proteostasis decline
Aging reduces chaperone capacity and autophagy flux, increasing the lifetime of misfolded proteins.
Mitochondrial vulnerability
Mitochondrial aging increases superoxide production and reduces energetic reserve.
Lysosomal bottleneck
Reduced lysosomal capacity limits clearance of aggregated or oxidatively damaged proteins.
Sleep and clearance
Poor sleep and reduced glymphatic flux can increase persistence of inflammatory signals.
Inflammaging
Chronic low-grade inflammation lowers the threshold for glial activation.
Motor unit fragility
Motor neurons have long axons and high metabolic demand, making redox stress more consequential.
Disorders & Diseases
Amyotrophic Lateral Sclerosis
A progressive motor neuron disease. SOD1 mutations account for a subset of familial cases.
Familial ALS (SOD1)
Autosomal-dominant SOD1 mutations can confer high risk with variable onset age.
Oxidative Stress
Redox imbalance can damage proteins, lipids, and DNA, and amplify mitochondrial stress.
Protein Misfolding
Misfolded SOD1 can behave as a seed in some models, increasing propagation risk.
Respiratory Decline
ALS progression is tracked with functional scales, respiratory measures, and NfL biomarkers.
Interventions
Supplements
Glutathione precursor studied for redox support and oxidative stress mitigation.
Mitochondrial electron transport cofactor studied in neurodegeneration contexts.
Lipid-soluble antioxidant; studied historically in oxidative stress contexts.
May support membrane health and inflammation balance.
Energy-buffering compound studied for neuromuscular support.
Lifestyle
Supports timely initiation of interventions that preserve quality of life in ALS.
Maintains function and reduces secondary complications from weakness.
Maintaining nutrition supports resilience; dysphagia requires proactive planning.
Sleep quality affects stress, inflammation, and resilience during chronic disease.
Medicines
Standard ALS therapy that modestly slows progression in some patients.
Antioxidant therapy used in ALS in some settings.
Antisense oligonucleotide therapy targeting SOD1 mRNA for SOD1-associated ALS.
Treat spasticity, cramps, saliva, and sleep issues to support quality of life.
Lab Tests & Biomarkers
Genetic Testing
Clinical sequencing confirms pathogenic SOD1 variants in suspected cases.
Panels may include SOD1, C9orf72, TARDBP, FUS, and others.
Fluid Biomarkers
Non-specific marker of axonal injury used for prognosis tracking in ALS.
In Tofersen therapy contexts, SOD1 levels may be monitored in trials.
Clinical/Physiology
Functional rating scale commonly used to track ALS progression.
Function tests guide timing of non-invasive ventilation.
Confirms lower motor neuron involvement in appropriate clinical context.
Hormonal Interactions
Cortisol Stress Factor
Chronic elevation can worsen sleep and amplify inflammatory signaling.
Thyroid hormone Metabolic Regulator
Dysfunction can worsen fatigue and weakness.
Insulin Metabolic Link
Systemic metabolic health influences inflammation and mitochondrial stress.
Testosterone Body Composition
Influences muscle mass and recovery, affecting function in neuromuscular disease.
Estrogen Neuroimmune
Sex hormones influence immune tone and may modulate neuroinflammation.
Melatonin Circadian
Supports sleep architecture, linked to stress resilience.
Deep Dive
Network Diagrams
SOD1 Misfolding and Aggregation
SOD1 Propagation and Glial Amplification
Mutant SOD1 Misfolding and Proteostasis Stress
Many ALS-associated SOD1 variants destabilize folding, metal binding, and dimerization. The resulting misfolded species can accumulate, stress mitochondria and ER proteostasis, and trigger downstream inflammatory cycles.
Destabilization: Metal loss, disulfide changes, and mutation-driven instability increase the population of partially unfolded SOD1 conformations.
Aggregation: Misfolded SOD1 can form oligomers and aggregates that burden chaperones, proteasome, and autophagy systems.
Cell stress amplification: Mitochondrial dysfunction and ER stress can increase reactive oxygen production, creating a feedback loop that further destabilizes proteins.
Non-cell-autonomous Toxicity and Propagation
ALS progression involves more than motor neurons. Astrocytes and microglia can amplify toxicity, and misfolded SOD1 can spread between cells in some models, increasing network-level stress.
Glial amplification: Activated glia can release inflammatory mediators and reduce metabolic support, increasing vulnerability of motor neurons.
Seed-like behavior: Misfolded SOD1 species can promote further misfolding in recipient cells, supporting a propagation model in some experimental systems.
Redox Biology and Motor Neuron Vulnerability
Motor neurons have long axons, high metabolic demand, and limited redundancy. When oxidative stress rises and proteostasis capacity falls, even modest destabilization of key proteins can become consequential.
In SOD1 ALS, this vulnerability is amplified by mutation-driven misfolding and by downstream mitochondrial and inflammatory feedback loops.
Relevant Research Papers
Links go to PubMed (abstracts are public); some papers also offer free full text via PMC or the publisher.
Identified SOD1 mutations as a cause of familial ALS.
Transgenic model demonstrating that mutant SOD1 expression drives ALS-like disease.
Evidence for prion-like propagation of misfolded SOD1 between cells.
Clinical trial of antisense therapy targeting SOD1 mRNA in SOD1 ALS.